- Report
- May 2025
- 163 Pages
Global
From €5359EUR$5,850USD£4,555GBP
- Report
- December 2024
Global
From €6870EUR$7,500USD£5,839GBP
- Report
- November 2024
- 153 Pages
Global
From €3664EUR$4,000USD£3,114GBP
- Report
- October 2024
- 182 Pages
Global
From €3248EUR$3,545USD£2,760GBP
€3608EUR$3,939USD£3,067GBP
- Report
- October 2024
- 185 Pages
Global
From €3248EUR$3,545USD£2,760GBP
€3608EUR$3,939USD£3,067GBP
- Report
- October 2024
- 183 Pages
Global
From €3248EUR$3,545USD£2,760GBP
€3608EUR$3,939USD£3,067GBP
- Report
- July 2024
- 137 Pages
Global
From €2747EUR$2,999USD£2,335GBP
- Report
- February 2025
- 300 Pages
Global
From €5451EUR$5,950USD£4,632GBP
- Report
- January 2025
- 230 Pages
Global
From €2281EUR$2,490USD£1,939GBP
- Report
- April 2025
- 175 Pages
Global
From €4113EUR$4,490USD£3,496GBP
- Report
- February 2025
- 187 Pages
Global
From €4122EUR$4,500USD£3,504GBP
- Report
- July 2024
- 150 Pages
Global
From €3435EUR$3,750USD£2,920GBP
- Report
- July 2024
- 100 Pages
Global
From €3435EUR$3,750USD£2,920GBP
- Report
- December 2024
- 200 Pages
Global
From €3435EUR$3,750USD£2,920GBP
- Report
- June 2024
- 140 Pages
Middle East, Africa
From €3297EUR$3,599USD£2,802GBP
- Report
- June 2024
- 140 Pages
Asia Pacific
From €3544EUR$3,869USD£3,012GBP
- Report
- June 2024
- 140 Pages
Europe
From €3544EUR$3,869USD£3,012GBP
- Report
- June 2024
- 120 Pages
North America
From €3544EUR$3,869USD£3,012GBP
- Report
- August 2024
- 174 Pages
North America
From €5492EUR$5,995USD£4,667GBP
- Report
- August 2024
- 167 Pages
Europe
From €5492EUR$5,995USD£4,667GBP

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon is a type of cardiovascular device used to treat coronary artery disease. It is a minimally invasive procedure that involves the insertion of a balloon-tipped catheter into the coronary artery. The balloon is then inflated to widen the artery and improve blood flow. PTCA balloons are typically made of polyethylene or polyurethane and are available in a variety of sizes and shapes. They are used in conjunction with other devices such as stents and guidewires to ensure optimal results.
The PTCA Balloon market is a rapidly growing segment of the cardiovascular device industry. It is driven by the increasing prevalence of coronary artery disease, technological advancements, and the growing demand for minimally invasive treatments. The market is highly competitive, with a number of companies offering a wide range of products.
Some of the major players in the PTCA Balloon market include Abbott Laboratories, Boston Scientific Corporation, Medtronic, Terumo Corporation, and B. Braun Melsungen AG. Show Less Read more